1
Taken into consideration , when using viral vectors for vaccination, including potentialTaken into consideration , when using viral vectors for vaccination, including potential integration, transcriptional activation of oncogenes, preexisting immunity against the viral vector and limitations , in transgenic capacity size. Several recombinant viral vectors, both RNA and DNA viruses, have been